This is a community-generated profile. If you would like to claim it, please .
ImmuVen Funding
$1.9M
22 rounds
ImmuVen is active in the following markets / industries: biotechnology. The company has secured funding across 2 rounds, totaling in an amount of $1.9M. Their most recent funding was raised on May 1, 2012.
Funding Rounds
U
$1700000U
$250000Investors of ImmuVen
National Institute for Allergy and Infectious Disease
Rounds
U